OSA screening with the pediatric sleep questionnaire for adolescents undergoing bariatric surgery in teen‐LABS

Ishman, Stacey L.; Heubi, Christine H; Jenkins, Todd M.; Michalsky, Marc P.; Simakajornboon, Narong; Inge, Thomas H.

doi:10.1002/oby.21623

Cited by 17 publications

(9 citation statements)

References 15 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The PSQ demonstrated poor sensitivity and specificity at varying AHI cut-offs in our snoring population. These findings are consistent with earlier failed attempts at utilizing the PSQ as an OSA screening tool for other high-risk populations, including craniofacial disorder and obesity 21,22 .…”

Section: Conflict Of Interest Statementsupporting

confidence: 90%

Sleep Apnea Screening in Children with Sickle Cell Anemia.

Flores-Oria

Stark

Mosquera

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Children with Sickle-Cell Anemia (SCA) are at high risk for obstructive sleep apnea (OSA). Screening for OSA is therefore recommended by current guidelines but no specific method described. The Pediatric Sleep Questionnaire (PSQ) is a validated detection tool for OSA in children. We assessed the utility of PSQ to screen for OSA in snoring children with SCA. Methods: A prospective study in children with SCA, aged 4 - 18 years. Subjects were assessed for snoring and PSQ administered at the same visit. All snoring children were then referred for polysomnography (PSG). Results: A total of 106 subjects were screened. Mean age was 10.5 years and 47.2% male. Snoring prevalence was 51/106 (48.1%). In the snoring group, OSA was detected in 83.9% (AHI ≥ 1.0/h) and 22.6% (AHI ≥ 5.0/h), respectively. Sensitivity and specificity of PSQ in snoring children was 46.2% and 20.0% (AHI ≥ 1.0/h), and 57.1% and 50.0% (AHI ≥ 5.0/h), respectively. Physician assessment of snoring had a high sensitivity of 70.3% but low specificity of 58.4% (AHI ≥1.0/h), and 87.5% and 41.5% (AHI ≥ 5.0/h), respectively. Conclusion: PSQ is a poor screening tool for detection of OSA in snoring children with SCA. Physician assessment of snoring however could be an initial approach prior to polysomnography.

show abstract

Section: Conflict Of Interest Statementsupporting

confidence: 90%

Sleep Apnea Screening in Children with Sickle Cell Anemia.

Flores-Oria

Stark

Mosquera

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Similarly, our study found physician assessment for snoring in children with SCA, at each health maintenance visit, to be a sensitive albeit non-specific screening measure. In the snoring population, poor sensitivity and specificity at varying AHI cut-offs is consistent with earlier failed attempts at utilizing the PSQ as an OSA screening tool for high-risk populations, including craniofacial disorder and obesity 22,23…”

Section: Discussionsupporting

confidence: 75%

“…In the snoring population, poor sensitivity and specificity at varying AHI cut-offs is consistent with earlier failed attempts at utilizing the PSQ as an OSA screening tool for high-risk populations, including craniofacial disorder and obesity. 22,23 Limitations in this real-world study include a PSG completion rate of 60.8% for the snoring group, possibly involving those with greater concerns about sleep-disordered breathing, which also compares to 66% PSG completion rate in the Sleep and Asthma Cohort. Referring a patient for a PSG involves time, education, and cost which are factors that may have negatively impacted our cohort (Fig.…”

Section: Discussionmentioning

confidence: 95%

Sleep Apnea Screening in Children With Sickle Cell Anemia

Oria

Stark

Mosquera

et al. 2022

Journal of Pediatric Hematology/Oncology

View full text Add to dashboard Cite

Background: Screening for obstructive sleep apnea (OSA) is recommended by current guidelines in children with sickle cell anemia (SCA), but no specific approach is described. The Pediatric Sleep Questionnaire (PSQ) is a validated detection tool for OSA in children. We assessed the utility of PSQ to screen for OSA in children with concomitant SCA and snoring. Materials and Methods: A prospective study, in children 4 to 18 years old with SCA. Subjects were assessed for snoring and PSQ administered at the same visit. All children with snoring were then referred for polysomnography. Results: A total of 106 subjects were screened. Habitual snoring prevalence was 51/106 (48.1%). In the snoring group, OSA was detected in 83.9% (apnea-hypopnea index [AHI] ≥1.0/h) and 22.6% (AHI ≥5.0/h), respectively. Sensitivity and specificity of PSQ in children with snoring was 46.2% and 20.0% (AHI ≥1.0/h), and 57.1% and 50.0% (AHI ≥5.0/h), respectively. Physician assessment for snoring had a high sensitivity of 70.3% but low specificity of 58.4% (AHI ≥1.0/h), and 87.5% and 41.5% (AHI ≥5.0/h), respectively. Conclusion: PSQ is a poor screening tool for detection of OSA in those children with SCA who snore. Physician assessment for snoring could however be an initial approach before polysomnography.

show abstract

“…The severity seems to increase with age, and children with OSA experience increased morbidity and mortality independent of other risk factors [58–60]. The prevalence of OSA is even greater among adolescents presenting for MBS, ranging from 46% to 70% [32,60,61]. Recent data demonstrate substantial improvement and/or resolution after MBS in adolescents, consistent with the outcomes in adults, with no increased morbidity or mortality [62,63].…”

Section: Obesity Disease-related Co-morbidities and Outcomesmentioning

confidence: 85%

ASMBS pediatric metabolic and bariatric surgery guidelines, 2018

Pratt

Browne

Browne³

et al. 2018

Surgery for Obesity and Related Diseases

Self Cite

415

285

View full text Add to dashboard Cite

The American Society for Metabolic and Bariatric Surgery Pediatric Committee updated their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009-2017) with 1387 articles and other supporting evidence through February 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the Centers for Disease Control and Prevention age- and sex-matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with class II obesity and a co-morbidity (listed in the guidelines), or with class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities, such as depressed health-related quality of life score, type 2 diabetes, obstructive sleep apnea, and nonalcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

show abstract

OSA screening with the pediatric sleep questionnaire for adolescents undergoing bariatric surgery in teen‐LABS

Cited by 17 publications

References 15 publications

Sleep Apnea Screening in Children with Sickle Cell Anemia.

Sleep Apnea Screening in Children with Sickle Cell Anemia.

Sleep Apnea Screening in Children With Sickle Cell Anemia

ASMBS pediatric metabolic and bariatric surgery guidelines, 2018

Contact Info

Product

Resources

About